Myomo Inc (MYO) reports a 154% revenue increase in Q4 2024, driven by expanded market access and positive adjusted EBITDA for the first time. BURLINGTON, Mass., March 10, 2025--Myomo, Inc. (NYSE ...
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback